Dendritic cell-T cell immunological synapse (DC-T cell IS)

The interaction between dendritic cell (DC) MHC-peptide complexes and T-cell receptors (TCR), along with co-stimulatory signals, constitutes the fundamental unit of adaptive immune initiation known as the immunological synapse (Grakoui et al., 1999, Science). Dendritic cells process antigens and present them via Major Histocompatibility Complex (MHC) molecules to naive T-cells to initiate a specific immune response (Banchereau & Steinman, 1998, Nature). Recognition of the MHC-peptide complex by a specific TCR (Signal 1) and the simultaneous engagement of co-stimulatory molecules like CD80/86 with CD28 (Signal 2) are required for robust T-cell activation, proliferation, and survival (Sharpe & Freeman, 2002, Nature Reviews Immunology). This complex interface is a primary focus of modern immunotherapy, where drugs aim to either enhance this interaction, such as in cancer vaccines like Sipuleucel-T, or modulate it to prevent overactivation using agents like Abatacept (Mellman et al., 2011, Nature). Dysregulation of this synapse, often through the upregulation of inhibitory 'checkpoint' molecules like PD-L1 or CTLA-4, can lead to immune evasion by tumors or the development of chronic inflammatory and autoimmune conditions (Chen & Mellman, 2013, Immunity).

Other names

MHC-peptide-TCR complexT-cell activation synapseAntigen-presenting cell-T cell interfaceSignal 1 and Signal 2 complex

Modulation of T-cell activation through the stabilization, enhancement, or blockade of the MHC-TCR and co-stimulatory receptor-ligand interactions.